What is ANI Pharmaceuticals's debt-to-assets?

ANI Pharmaceuticals (ANIP) reported debt-to-assets of 0.2× in Q1 2026.

How has ANI Pharmaceuticals's debt-to-assets changed year-over-year?

ANI Pharmaceuticals's debt-to-assets decreased by 12.3% year-over-year, from 0.2× to 0.2×.

What is the long-term trend for ANI Pharmaceuticals's debt-to-assets?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's debt-to-assets has grown at a -11.2% compound annual growth rate (CAGR), from 0.4× to 0.2×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

ANI Pharmaceuticals ANIP Debt-to-assets

Debt-to-assets at other companies

Amneal Pharmaceuticals, Inc.AMRX

0.7×+0.1×

ViatrisVTRS

0.4×0.0×

AnaptysBio, Inc.ANAB

0×—

ALN

Alnylam PharmaceuticalsALNY

0.1×0.0×

Aurinia PharmaceuticalsAUPH

0.1×-0.1×

AmgenAMGN

0.6×0.0×

Other financials

Income statement

See full

Revenue$237.5M+20.5%

Gross profit$143.9M+16.0%

Operating income$38.9M+48.5%

Net income$29.5M+88.1%

EPS (diluted)$1.28+85.5%

Balance sheet

See full

Cash & equivalents$311.2M+108%

Total debt$305.3M-3.5%

Total equity$562.3M+34.3%

Total assets$1.4B+10.0%

Cash flow

See full

Operating cash flow$58.4M+66.8%

CapEx$6.1M+146%

Free cash flow$52.3M+60.8%

Valuation

See full

Market cap$1.89B+18.3%

Enterprise value$1.88B+5.8%

P/E20.5×—

P/S2×-0.3×

Profitability

See full

Gross margin60.8%+1.5pp

Operating margin13.4%—

Net margin10%+8.1pp

FCF margin20.7%+10.8pp

Returns & leverage

See full

Return on equity18.8%+15.6pp

Debt / equity0.5×-0.2×

Current ratio3.1×+0.5×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

total debt/total assets=0.2×

Based on the most recent quarter.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ANI Pharmaceuticals's debt-to-assets?: ANI Pharmaceuticals (ANIP) reported debt-to-assets of 0.2× in Q1 2026.
How has ANI Pharmaceuticals's debt-to-assets changed year-over-year?: ANI Pharmaceuticals's debt-to-assets decreased by 12.3% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for ANI Pharmaceuticals's debt-to-assets?: Over 5 years (2020 to 2025), ANI Pharmaceuticals's debt-to-assets has grown at a -11.2% compound annual growth rate (CAGR), from 0.4× to 0.2×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.